fda semaglutide lawsuit Novo Nordisk and Hims & Hers settle lawsuit, allowing the telehealth platform to sell FDA-approved Wegovy and Ozempic GLP-1 drugs. Tap link in bio for full story Ofa Fda Compounded Semaglutide Lawsuit

If you've been having trouble losing weight, you may have considered taking a supplement advertised as a fat burner

Some people feel full after just a few bites, forget to eat, or experience nausea, reflux, or constipation

The trial excluded people with type 2 diabetes

Practical Steps for Starting Semaglutide with a Thyroid Condition Before beginning any GLP-1 therapy, patients with thyroid disease should confirm their TSH and thyroid antibodies (TPO, thyroglobulin) are stable and well-documented

Semaglutide, a GLP-1 receptor agonist approved for type 2 diabetes and weight management, raises important safety questions for patients with ulcerative colitis